Some problems with OTC Drug Facts labels required in the US are worse than others and some likely can be corrected with minor changes to the format, labeling experts agreed during a recent Food and Drug Administration webinar.
Other changes, notably for supporting OTC labeling for drugs that currently are available Rx-only and are indicated for chronic, more complicated conditions, aren’t minor and won’t happen within the limits of one-dimensional text media
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?